Grade IV Astrocytoma
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma (NCT04757662) | Washington University School of Medicine | 2021-05-14 |
| Surgical Nivolumab And Ipilimumab For Recurrent GBM (NCT04606316) | Patrick Wen, MD | 2021-02-01 |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma (NCT02858895) | Medicenna Therapeutics, Inc. | 2017-04-11 |
| Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma (NCT01700569) | Institut Cancerologie de l'Ouest | 2013-01-01 |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma (NCT01290692) | TVAX Biomedical | 2011-06-01 |
| Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) | Northwest Biotherapeutics | 2006-12-01 |
Track Grade IV Astrocytoma automatically
Every clearance here is in the API, with alerts when new ones post.